Supernova Pharmaceuticals Private Limited
About Supernova Pharmaceuticals Private Limited
Data last updated:
Supernova Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC304616. Its GSTIN is 07AAXCS4638J1ZK (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Om Prakash Tanwar and Rukmani.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at B – 11 Somdutt Chamber – II Bhikaji Cama Place New Delhi – 110066, Delhi, India – 110066.
As per the financials filed for FY 2019, the company reported a revenue of ₹3.9 Lakh, a growth of 120% compared to the previous year. For the same year it recorded a net loss of ₹69,901 (net margin -17.9%) and EBITDA of -₹69,722 (EBITDA margin -17.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Supernova Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 11 Somdutt Chamber – II Bhikaji Cama Place New Delhi – 110066, Delhi, India – 110066
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Supernova Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Supernova Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Supernova Pharmaceuticals Private Limited, buy the company report.
Financials of Supernova Pharmaceuticals Private Limited
FY 2019 filings availableSupernova Pharmaceuticals Private Limited reported revenue of ₹3.9 Lakh (up 120% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 120% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹3.9 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹69,722 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹69,901 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -17.9% | ||
| Net Profit Margin | -17.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Supernova Pharmaceuticals Private Limited, buy the company report.
Board of directors of Supernova Pharmaceuticals Private Limited
Supernova Pharmaceuticals has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Om Prakash Tanwar Also directs: Botanic Green Private Limited | Director | 17 Feb 2021 | 5 Years 8 Months | Current |
| Rukmani | Director | 24 Nov 2018 | 7 Years 11 Months | Current |
| Mohan Singh Rawat | Director | 24 Nov 2018 | 7 Years 11 Months | Current |
| Rahul Malik Also directs: Oceans Apart AI LLP, Kumra Foods Private Limited, Fireexpert Consultants Private Limited and 4 more | Director | 17 Feb 2021 | 5 Years 8 Months | Current |
| Devi Dayal | Director | 24 Nov 2018 | 7 Years 11 Months | Current |
| Amardeep Kaur | Director | 17 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Supernova Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dadaz Pharmaceuticals Private Limited | ₹3.95 Lakh (FY 2024) | 81.0% | Ahmedabad, Gujarat, India | |||
| Supernova Pharmaceuticals Private Limitedthis company | ₹3.9 Lakh (FY 2019) | -₹69,901 | -17.9% | 120.0% | New Delhi, Delhi, India | |
| Abiotic Pharmaceuticals Private Limited | ₹3.89 Lakh (FY 2025) | -25.0% | Gorakhpur, Uttar Pradesh, India | |||
| Triocure Pharmaceuticals Private Limited | ₹3.86 Lakh (FY 2020) | Bishnah, Jammu and Kashmir, India |
To see the full peer comparison of Supernova Pharmaceuticals Private Limited, buy the company report.
Auditor
Supernova Pharmaceuticals Private Limited is audited by MITTAL GAURAV & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MITTAL GAURAV & ASSOCIATES | FY 2019 | 028523N |
Shareholding
The shareholding of Supernova Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Supernova Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Supernova Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supernova Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Supernova Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAXCS4638J1ZK | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Supernova Pharmaceuticals Private Limited, buy the company report.
Recent activity
Supernova Pharmaceuticals Private Limited has 12 board changes on record since 2018: 6 appointments and 6 cessations. The latest: Ajeet Singh ceased to be Director on 17 Feb 2021.
3 earlier events are in the company report.
Frequently asked questions
Supernova Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 August 2016 (10+ years old) and is registered under CIN U74999DL2016PTC304616.
Supernova Pharmaceuticals has 6 current directors:
- Om Prakash Tanwar - Director
- Rukmani - Director
- Mohan Singh Rawat - Director
- Rahul Malik - Director
- Devi Dayal - Director
- Amardeep Kaur - Director
The latest financial statements of Supernova Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Supernova Pharmaceuticals is 07AAXCS4638J1ZK, registered in Delhi.
The CIN (Corporate Identification Number) of Supernova Pharmaceuticals is U74999DL2016PTC304616. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supernova Pharmaceuticals was incorporated on 18 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Supernova Pharmaceuticals by revenue are Dadaz Pharmaceuticals Private Limited, Abiotic Pharmaceuticals Private Limited, Triocure Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajeet Singh ceased to be Director on 17 Feb 2021. Amardeep Kaur was appointed as Director on 17 Feb 2021. Om Prakash Tanwar was appointed as Director on 17 Feb 2021. Supernova Pharmaceuticals has 12 board changes on record in total.
The registered office of Supernova Pharmaceuticals is at B – 11 Somdutt Chamber – II Bhikaji Cama Place New Delhi – 110066, Delhi, India – 110066.
Supernova Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Supernova Pharmaceuticals is compliant as of 29 September 2026. The company is actively filing with the Registrar of Companies.